No Data
Aclaris Therapeutics And 3 Other Stocks Under $2 Insiders Are Buying
Analysts Offer Insights on Healthcare Companies: Aclaris Therapeutics (ACRS), Celcuity (CELC) and Intuitive Surgical (ISRG)
H.C. Wainwright Maintains Aclaris Therapeutics(ACRS.US) With Hold Rating
H.C. Wainwright analyst Ram Selvaraju maintains $Aclaris Therapeutics(ACRS.US)$ with a hold rating.According to TipRanks data, the analyst has a success rate of 41.2% and a total average return of 2.9
HC Wainwright & Co. Reiterates Neutral on Aclaris Therapeutics
Aclaris Therapeutics Analyst Ratings
Aclaris Therapeutics Announces Sale of OLUMIANT Royalties and Milestones to OMERS Life Sciences for Up to $31.5 Million
No Data